AC
AQST icon

AXQ Capital’s Aquestive Therapeutics AQST Stock Holding History

AXQ Capital’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Sell
28,100
-19,868
-41% -$83.6K 0.01% 810
2026
Q1 		$199K Sell
47,968
-8,399
-15% -$34.1K 0.03% 754
2025
Q4 		$364K Sell
56,367
-12,867
-19% -$80.2K 0.08% 370
2025
Q3 		$387K Buy
+69,234
New +$299K 0.15% 251

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

AXQ Capital's AQST Position: Q2 2026 in Review

AXQ Capital reduced its Aquestive Therapeutics (AQST) stake by 41% in Q2 2026, selling an estimated $83.6K and leaving 28,100 shares worth $117K. The position accounts for 0.01% of the portfolio, ranked #810.

AXQ Capital first reported a position in AQST in Q3 2025 and has held it in 4 quarters since. The position peaked at $387K in Q3 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • AXQ Capital held 28,100 shares of Aquestive Therapeutics worth $117K as of Q2 2026.
  • AXQ Capital sold 19,868 Aquestive Therapeutics shares in Q2 2026, an estimated $83.6K.
  • Aquestive Therapeutics made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #810 holding.
  • AXQ Capital first reported a position in Aquestive Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • AXQ Capital's Aquestive Therapeutics position peaked at $387K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.